首页 > 产品目录 > 信号通路 > Protein Tyrosine Kinase/RTK > IGF-1R > 顺式-3-(8-氨基-1-(2-苯基喹啉-7-基)咪唑并[1,5-a]吡嗪-3-基)-1-甲基环丁醇; 林西替尼

顺式-3-(8-氨基-1-(2-苯基喹啉-7-基)咪唑并[1,5-a]吡嗪-3-基)-1-甲基环丁醇; 林西替尼

ChemLeader 98+%

Linsitinib (Synonyms: OSI-906; Cis-3-(8-Amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutan-1-ol)

产品编号:CL2468 CAS No.:867160-71-2 MDLNo: 分子式:C26H23N5O 分子量:421.49
规格 库存 目录价 会员专享价 数量
1 mg 3-5days ¥500.00 登录后可见
- +
5 mg 3-5days ¥980.00 登录后可见
- +
10 mg 3-5days ¥1600.00 登录后可见
- +

化学品安全说明书(MSDS)

下载MSDS
  • 基本信息
  • 相关文档
  • 产品详情
  • 相关文献
基本信息
英文名称 Linsitinib (Synonyms: OSI-906; Cis-3-(8-Amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutan-1-ol)
中文名称顺式-3-(8-氨基-1-(2-苯基喹啉-7-基)咪唑并[1,5-a]吡嗪-3-基)-1-甲基环丁醇; 林西替尼
CAS号867160-71-2
分子式C26H23N5O
分子量421.49
外观White to yellow powder
储存条件Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
产品详情

Linsitinib (formerly OSI-906; OSI 906) is a firs-in-class, ATP-competitive and orally bioavailable dual inhibitor of and insulin receptor (IR) and insulin-like growth factor-1 receptor (IGF-1R) with potential antitumor activity. It exhibits modest potency against InsR with an IC50 of 75 nM, and it has no activity against other kinases like Abl, ALK, BTK, EGFR, FGFR1/2, PKA, and so on. In cell-free assays, it inhibits IGF-1R with an IC50 of 35 nM.
Tags: buy Linsitinib | purchase Linsitinib | Linsitinib cost | order Linsitinib | Linsitinib chemical structure | Linsitinib in vivo | Linsitinib in vitro | Linsitinib formula | Linsitinib molecular weight

相关文献
抱歉,暂时没有相关文献
相关产品
抱歉,暂时没有相关产品
在线客服
小德
021-58180488
小立
021-58180488
在线服务时间: 工作日 9:00-18:00